Consumer Insights
Uncover trends and behaviors shaping consumer choices today
Procurement Insights
Optimize your sourcing strategy with key market data
Industry Stats
Stay ahead with the latest trends and market analysis.
Report Overview
The uterine fibroids market was valued at USD 12.50 Billion in 2023, driven by advancements in treatment options across the 8 major markets. The market is expected to grow at a CAGR of 7.30% during the forecast period of 2024-2032, with the values likely to reach USD 23.57 Billion by 2032.
2023
Base Year
2017-2023
Historical Year
2024-2032
Forecast Year
- The strong regulatory backing from health authorities is expected to elevate the market value in the coming years.
- In May 2024, Aster RV Hospital in Bengaluru made history in South India by successfully removing a 4 kg fibroid from a patient's uterus through laparoscopic surgery. Thus, the utilization of innovative treatments in hospitals is a significant market trend.
- Continuous research and development to enhance treatment options is anticipated to boost market value.
Uterine Fibroids Market Overview
Uterine fibroids, which are non-cancerous growths located in the uterus, are frequently seen in women of African descent. Possible symptoms are menstrual bleeding, pelvic pain, frequent urination, bloating, and reproductive problems. Diagnosis is conducted through pelvic exams, imaging procedures, and blood tests, and treatment is tailored according to the symptoms. Increased demand for fertility-preserving treatments and the development of symptomatic treatments are expected to drive the market growth in the forecast period.
Uterine Fibroids Market Growth Drivers
Technological Advancement and Innovation in Treatment Options to Drive Market Growth
Advancements in technology and innovation in treatment options are causing a rise in demand in the market for uterine fibroids. UConn Health, a hospital in the United States, has implemented the Sonata® treatment, demonstrating a revolutionary option to standard surgeries and providing patients with a less invasive choice that allows for quicker recovery and better results. Thus, the advancement in medical technology is one of the primary drivers of the market.
Uterine Fibroids Market Trends
The market is witnessing several trends and developments to improve the current scenario. Some of the notable trends are as follows:
Uterine Fibroids Market Segmentation
The market report offers a detailed analysis of the market based on the following segments:
Market Breakup by Drug Class
- Progestin-Releasing Intrauterine Device (IUD)& Contraceptives
- Gonadotropin-Releasing Hormone (GnRH) Antagonists
- Gonadotropin-Releasing Hormone (GnRH) Agonists
- Non-Hormonal Medications
- Others
Market Breakup by Type
- Subserosal Fibroids
- Intramural Fibroids
- Submucosal Fibroids
- Pedunculated Fibroids
- Others
Market Breakup by End User
- Hospitals
- Clinics
- Diagnostic Centers
- Research Laboratories
- Others
Market Breakup by Region
- United States
- EU-4 and the United Kingdom
- Germany
- France
- Italy
- Spain
- United Kingdom
- Japan
- India
Uterine Fibroids Market Share
Market Segmentation Based on the Type to Witness Growth
The uterine fibroid market segmentation, based on type, includes subserosal fibroids, intramural fibroids, submucosal fibroids, and pedunculated fibroids, among others. Submucosal fibroids are expected to dominate the market, with emerging economies experiencing category expansion due to their development in the muscle layer of the uterus. Intramural fibroids are also increasing, impacting fertility rates, and requiring treatment.
Uterine Fibroids Market Analysis by Region
Based on region, the market report covers the United States, EU-4 (Germany, France, Italy, Spain), United Kingdom, Japan, and India. The United States is expected to dominate the market share owing to the rising prevalence of uterine fibroids, increasing pregnancy complications due to fibroids, and the approval of novel treatment options.
Leading Players in the Uterine Fibroids Market
The key features of the market report include patent analysis, clinical trials analysis, grant analysis, funding, and investment analysis, and strategic initiatives by the leading players. The major companies in the market are as follows:
Pfizer Inc.
Pfizer Inc. is a United States-based pharmaceutical company specializing in biopharmaceuticals for cardiovascular, metabolic, and women's health. In January 2024, Pfizer Canada collaborated with Sumitomo Pharma Canada to offer MYFEMBREE® for endometriosis and uterine fibroids in Canada.
AbbVie Inc.
AbbVie Inc. based in North Chicago, Illinois, is a pharmaceutical company specializing in the development and ...
ObsEva
ObsEva SA is a clinical-stage biopharmaceutical company focusing on developing novel therapies for women's rep...
Bayer AG
Bayer AG is a German pharmaceutical and biotechnology company that focuses on innovative solutions for disease...
*Please note that this is only a partial list; the complete list of key players is available in the full report. Additionally, the list of key players can be customized to better suit your needs.*
Other players in the market include AstraZeneca.
Key Questions Answered in the Uterine Fibroids Market Report
- What was the uterine fibroids market value in 2023?
- What is the uterine fibroids market forecast outlook for 2024-2032?
- What are the regional markets covered in the EMR report?
- What is the market segmentation based on type?
- What is the market segmentation based on the drug class?
- What is the market breakup based on the end user?
- What are the major factors aiding the uterine fibroids market demand?
- How has the market performed so far and how is it anticipated to perform in the coming years?
- What are the major drivers, opportunities, and restraints in the market?
- What are the major trends influencing the market?
- Which regional market is expected to dominate the market share in the forecast period?
- Which country is likely to experience elevated growth during the forecast period?
- Who are the key players involved in the uterine fibroids market?
- What is the patent landscape of the market?
- What are the current unmet needs and challenges in the market?
- How are partnerships, collaborations, mergers, and acquisitions among the key market players shaping the market dynamics?
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Looking for specific insights?
Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!
Report Summary
Explore our key highlights of the report and gain a concise overview of key findings, trends, and actionable insights that will empower your strategic decisions.
| REPORT FEATURES | DETAILS |
| Base Year | 2023 |
| Historical Period | 2017-2023 |
| Forecast Period | 2024-2032 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Drug Class |
|
| Breakup by Type |
|
| Breakup by End User |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Supplier Landscape |
|
| Companies Covered |
|
Purchase Full Report
Datasheet
- Selected Sections, One User
- Printing Not Allowed
- Email Delivery in PDF
Free Limited CustomisationPost Sales Analyst Support50% Discount on Next Update
Single User License
One User
- All Sections, One User
- One Print Allowed
- Email Delivery in PDF
Free Limited CustomisationPost Sales Analyst Support50% Discount on Next Update
Five User License
Five Users
- All Sections, Five Users
- Five Prints Allowed
- Email Delivery in PDF
- Free Limited Customisation
- Post Sales Analyst Support
50% Discount on Next Update
Corporate License
Unlimited Users
- All Sections, Unlimited Users
- Unlimited Prints Allowed
- Email Delivery in PDF + Excel
- Free Limited Customisation
- Post Sales Analyst Support
- 50% Discount on Next Update
How To Order
Our step-by-step guide will help you select, purchase, and access your reports swiftly, ensuring you get the information that drives your decisions, right when you need it.
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.
Subscribe to our Newsletter
By subscribing you agree to with our privacy policy and provide
consent to
receive
updates
from our company.
Our Offices
Australia
63 Fiona Drive, Tamworth, NSW
+61 448 06 17 27
India
C130 Sector 2 Noida, Uttar Pradesh 201301
+91-858-608-1494
Philippines
40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City,1226.
+63 287899028, +63 967 048 3306
United Kingdom
6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London
+44-753-713-2163
United States (Head Office)
30 North Gould Street, Sheridan, WY 82801
+1-415-325-5166
Vietnam
193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City
+84865399124